JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Autres langues Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Actions

688076

CNE1000051X5

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
56,8 ^CNY	-1,22%		-7,10%	+26,36%

22/04	Jiangsu Sinopep-Allsino Biopharmaceutical Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/02	Sinopep-Allsino Bio Pharmaceutical Co. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sinopep-Allsino Biopharmaceutical's Raw Drug Material Gets OK to Submit Drug Application to US FDA; Shares Up 4%	19/12
Sinopep-Allsino Biopharmaceutical Gets Nod to Issue Convertible Bonds	17/11
Sinopep-Allsino’s Hypertension Drug Shortlisted for China’s Drug Procurement Program	08/11
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(XSSC:688076) added to S&P Global BMI Index	18/09/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.	08/06/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/04/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding	21/04/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	18/10/22
Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm	28/09/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Zhejiang Zhongcheng Pharmaceutical Co., Ltd. agreed to acquire 45% stake in Hangzhou Xinbosi Biopharmaceutical Co., Ltd. from Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. for CNY 13.5 million.	30/06/22
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2022.	21/05/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange Composite Index	20/05/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange A Share Index	20/05/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Actions

688076

CNE1000051X5

Autres langues

Filtres